Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice

Kidney International

Volumn 54, Issue 6, 1998, Pages 1999-2007

  Zheng, Feng ^b   Striker, Gary E ^b   Esposito, Ciro ^b   Lupia, Enrico ^b   Striker, Liliane J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Diabetes; Glomerular lesions; Insulin; Nephropathy; Sclerosis; Susceptibility to GS

Indexed keywords

COLLAGEN TYPE 4; LAMININ; MESSENGER RNA; STREPTOZOCIN; TENASCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERGLYCEMIA; MOUSE; MOUSE STRAIN; NEPHRON; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOZOCIN DIABETES;

EID: 0031754703     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00219.x     Document Type: Article

References (36)

1. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CN: The changing natural history of nephropathy in Type I diabetes. Am J Med 78:785-794, 1985
2. BORCH-JOHNSEN K, KREINER S: Proteinuria: Value as a predictor of cardiovascular mortality in insulin-dependent diabetes. Br Med J 294:1651-1654, 1987
3. ØSTERBY R, PARVING HH, HOMMEL E, JØRGENSEN HE, LOKKEGAARD H: Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes 39:1057-1063, 1990
4. YANG CW, VLASSARA H, PETEN EP, HE CJ, STRIKER GE, STRIKER LJ: Advanced glycosylation end-products upregulate gene expression found in diabetic glomerular disease. Proc Nat Acad Sci USA 91:9436-9440, 1994
5. ESPOSITO C, LIU ZH, STRIKER GE, PHILLIPS C, CHEN NY, CHEN WY, KOPCHICK JJ, STRIKER LJ: Inhibition of diabetic nephropathy by a GH antagonist: A molecular analysis. Kidney Int 50:506-514, 1996
6. BORCH-JOHNSEN K, NØGAARD K, HOMMEL E, MATHIESEN ER, JENSEN JS, DECKERT T, PARVING; HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
7. BALLARD DJ, HUMPHREY LL, MELTON LJ III, FROHNART PP, CHU PC, O'FALLEN WM, PALUMBO PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
8. COWIE CC, PORT FK, WOLFE RA, SAVAGE PJ, MOLL PP, HAWTHORNE M: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
9. KIPROV DD, COLVIN RB, MCCLUSKEY RT: Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 46:275-281, 1982
10. ROSSING P, TARNOW L, NIELSEN FS, HANSEN BV, BRENNER BM, PARVING HH: Low birth weight: A risk factor for development of diabetic nephropathy? Diabetes 44:1405-1407, 1995
11. LEROY B, JOSSET P, MORGAN G, COSTIL J, MERLET-BENICHOU C: Intrauterine growth retardation (IUGR) and nephron deficit: Preliminary study in man. (abstract) Pediatr Nephrol 5:C21, 1991
12. BRENNER BM, CHELRTOW GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994
13. GILBERT T, LELIEVRE-PEGORIER M, MERLET-BENICHOU C: Long-term effects of mild oligonephronia induced in utero by gentamicin in the rat. Pediatr Res 30:450-456, 1991
14. HE CJ, ESPOSITO C, PHILLIPS C, ZALUPS RK, HENDERSON DA, STRIKER GE, STRIKER LJ: Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97:1242-1249, 1996
15. PETEN EP, GARCIA-PEREZ A, TERADA Y, WOODROW D, MARTIN BM, STRIKER GE, STRIKER LJ: Age-related changes in a1- and a2-chain type IV collagen mRNAs in adult mouse glomeruli: Competitive PCR. Am J Physiol 263:F951-F957, 1992
16. MACKAY K, STRIKER LJ, STAUFFER JW, AGODOA LY, STRIKER GE: Relationship of glomerular hypertrophy and selerosis: Studies in SV40 transgenic mice. Kidney Int 37:741-748, 1990
17. DOI T, HATTORI M, AGODOA LYC, SATO T, YOSHIDA H, STRIKER LJ, STRIKER GE: Glomerular lesions of the non-obese diabetic mouse: Before and after the onset of hyperglycemia. Lab Invest 63:204-211, 1990
18. PESCE CM, STRIKER LJ, PETEN EP, ELLIOT SJ, STRIKER GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605, 1991
19. YANG CW, HATTORI M, VLASSARA H, HE CJ, CAROME MA, YAMATO E, ELLIOT S, STRIKER GE. STRIKER LJ: Overexpression of TGF-β1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in non-obese diabetic mice. J Am Soc Nephrol 5:1610-1617, 1995
20. SEAQUIST ER, GOETZ FE, RICE S, BARBOSA J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
21. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic susceptibility to nephropathy in insulin-dependent diabetes: From epidemiology to molecular genetics. Diabetes Metabol Rev 11:287-314, 1995
22. PARVING HH, TARNOW L, ROSSING P: Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2501-2517, 1996
23. VAN LIEW JB, YANG CW, STRIKER LJ, FELD LG: Resistance to glomerulosclerosis in biobreeding rats, (abstract) J Am Soc Nephrol 5:973, 1994
24. FELD LG, CACHERO S, ELLIS EN, DEDEOGLU O, UEDA Y, LEONARD C, LETIZIA R, MALLON V, VAN LIEW JB: Resistance to glomerular injury in the diabetic biobreeding rat. Exper Physiol 80:991-1000, 1995
25. STRIKER GE, NAGLE RB, KOHNEN PW, SMUCKLER EA: Response to unilateral nephrectomy in old rats. Am Assoc Arch Pathol 87:439-442, 1969
26. KREISBERG JI, KARNOVSKY MJ: Focal segmental sclerosis in the Fawn-hooded rat. Am J Pathol 92:637-652, 1978
27. MATSUYAMA M, OGIU T, KONTANI K, YAMADA C, KAWAI M, HIAI H, NAKAMURA Y, SHIMUZU F, TOYOKAWA T, KINOSHITA Y: Genetic regulation of the development of glomerular sclerotic lesions in the BUF/Mna rat. Nephron 54:334-337, 1990
28. BRANDIS A, BIANCHI G, REALE E, HELMCHEN U, KUHN K: Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. Lab Invest 55:234-243, 1986
29. BROWN DM, PROVOOST AP, DALY MJ, LANDERS EJ, JACOB HJ: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Med 12:44-51, 1996
30. FOGARTY DG, KROLEWSKI AS: Genetic susceptibility and the role of hypertension in diabetic nephropathy. Curr Opin Nephrol Hypertens 6:184-191, 1997
31. STRIKER GE, HE CJ, LIU ZH, YANG DCW, ZALUPS RK, ESPOSITO C, STRIKER LJ: Pathogenesis of non-immune glomerulosclerosis: Studies in animals and potential applications to humans. Lab Invest 73:596-605, 1995
32. FUKUI M, NAKAMURA T, EBIHARA I, SHIRATO I, TOMINO Y, KOIDE H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
33. LEDBETTER S, COPELAND EJ, NOONAN D, VOGELI G, HASSELL JR: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthesis inhibition. Diabetes 39:196-203, 1990
34. ZATZ R, FUJIHARA K: Glomerular hypertrophy and progressive glomerulopathy. Is there a definite pathogenetic correlation? Kidney Int 45(Suppl 45):S27-S29, 1994
35. PESCE CM, SCHMIDT K, FOGO A, OKOYE ML, KIM R, STRIKER LJ, STRIKER GE: Glomerular size and the incidence of renal disease in African Americans and Caucasians. J Nephrol 7:355-359, 1994
36. YOUNG BA, JOHNSON RJ, ALPERS CE, ENG E, GORDON K, FLOEGE J. COUSER WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995